| Titre | Treatment of conjunctival melanoma |
| Abstract Nr. | 149 |
| But | To describe the diagnosis, treatment and outcome of 200 conjunctival melanomas treated between 1950 and 2005 retrospectively. |
| Méthodes | Retrospective descriptive study. |
| Résultats | The origin of the conjunctival melanoma was nevus (12), primary acquired melanosis (PAM) (113), de novo (52), or not known (23). Out of 200 patients, 114 had a local recurrence, during the median follow-up of 7.1 years (range 1.5-50.5 years). Non-epibulbar localisation was the most important risk factor for local recurrence and survival. Significantly fewer local recurrences occurred with tumors initially treated with excision and adjuvant brachytherapy ( Sr 90 ), in comparison with tumors treated with excision only or with excision with cryotherapy. Mean tumor thickness was 2.1 mm (standard deviation 1.9 mm). Tumor thickness was also a prognostic factor for survival. Forty three patients had regional lymph node metastases, mostly to the preauricular lymph nodes. Fifty patients had a distant metastases mainly to the liver and lung. Tumor-related survival was 86.5% at 5 years, 72% at 10 years and 67% at 15 years. |
| Conclusion | Poor survival was associated with a non-epibulbar melanoma and thicker tumors. In this study, fewer local recurrences were seen when excision was combined by brachytherapy. |
| Nom | MISSOTTEN |
| Initiales | GS |
| Institut | Leiden University Medical Center |
| Ville | Leiden |
| Nom | de Wolff-Rouendaal |
| Initiales | D |
| Institut | Leiden University Medical Center |
| Ville | Leiden |
| Nom | Tassignon |
| Initiales | MJ |
| Institut | Universitair Ziekenhuis Antwerpen |
| Ville | Antwerpen |
| Nom | de Keizer |
| Initiales | RJ |
| Institut | Universitair Ziekenhuis Antwerpen en Leiden University Medical Center |
| Ville | Antwerpen |